Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/22/2026

Anemia Diagnosis and Treatment

Diagnostic Approach

  • The World Health Organization defines anemia as hemoglobin < 12 g/dL in non-pregnant women, < 11 g/dL in pregnant women, and < 13 g/dL in men, according to the American Society of Hematology 1, 2
  • Regular monitoring is recommended, especially in high-risk patients, such as those with chronic diseases, inflammatory bowel disease, or chronic kidney disease, as suggested by the National Kidney Foundation 3, 4
  • A complete blood count with red cell indices, reticulocyte count, serum ferritin, transferrin saturation, and C-reactive protein concentration are essential for the initial workup, as recommended by the European Crohn's and Colitis Organisation 2, 3
  • Microcytic anemia (MCV < 80 fL) most commonly indicates iron deficiency anemia, while normocytic anemia (MCV 80-100 fL) may indicate hemorrhage, hemolysis, or anemia of chronic inflammation, according to the American College of Gastroenterology 5
  • Macrocytic anemia (MCV > 100 fL) may indicate vitamin B12 or folate deficiency, as suggested by the National Comprehensive Cancer Network 5
  • A low or normal reticulocyte count indicates impaired erythropoiesis, while an elevated reticulocyte count suggests increased red cell production, according to the American Society of Hematology 2, 3

Treatment Approach

  • For suspected iron deficiency, diagnostic criteria depend on inflammation status, and serum ferritin < 30 μg/L confirms iron deficiency without inflammation, as recommended by the European Crohn's and Colitis Organisation 6
  • For suspected vitamin deficiencies, measuring vitamin B12 and folate levels is essential, as suggested by the National Comprehensive Cancer Network 2, 3
  • For suspected hemolysis, measuring haptoglobin, LDH, and bilirubin is necessary, according to the American College of Gastroenterology 2, 3
  • Anemia of chronic disease should be treated by addressing the underlying condition, and erythropoietin therapy may be considered in specific situations, such as chronic kidney disease, as recommended by the National Kidney Foundation 4, 7
  • Folate deficiency should be treated with oral folate supplementation, but high-dose folic acid may mask B12 deficiency symptoms, according to the American College of Gastroenterology 2

Management of Anemia with Elevated RDW

Initial Assessment of Anemia

  • The patient's CBC shows anemia with low hemoglobin, low hematocrit, and low RBC count, indicating significant anemia requiring further evaluation, according to Kidney International Supplements 8
  • The normal MCV with elevated RDW suggests a normocytic anemia with increased red cell size variation, which can indicate early iron deficiency, mixed nutritional deficiencies, or other causes, as reported by MMWR Recommendations and Reports 9
  • The low MCHC suggests hypochromia, which often accompanies iron deficiency even when MCV remains normal, as noted by Kidney International Supplements and MMWR Recommendations and Reports 8, 10
  • Obtain iron studies including serum ferritin, transferrin saturation, and total iron-binding capacity to assess iron status, as recommended by Kidney International Supplements 8
  • Measure reticulocyte count to evaluate bone marrow response to anemia, as suggested by Kidney International Supplements 8

Clinical Considerations

  • Assess for potential sources of blood loss, as iron deficiency in adults often indicates ongoing blood loss, according to Kidney International Supplements 8
  • In patients without obvious blood loss, gastrointestinal evaluation may be warranted, as noted by MMWR Recommendations and Reports 10
  • For severe symptomatic anemia, consider blood transfusion, particularly if the patient is experiencing fatigue, dizziness, or hypotension, as recommended by The Journal of the American Academy of Orthopaedic Surgeons 11

Iron Deficiency Diagnosis and Management

Diagnostic Markers

  • MCH is a more reliable marker of iron deficiency than MCHC because it is less dependent on storage conditions and the counting machine used, and a reduction occurs in both absolute and functional iron deficiency 12
  • Serum ferritin is the single most useful marker, with levels <30 μg/L confirming iron deficiency in the absence of inflammation 12
  • Transferrin saturation <15-16% supports iron deficiency and is less affected by inflammation than ferritin 13, 14

Diagnostic Workup

  • Obtain iron studies, including serum ferritin and transferrin saturation, to confirm or exclude iron deficiency 12, 13, 14
  • Measure reticulocyte count to evaluate bone marrow response to any underlying anemia 13

Clinical Considerations

  • Ferritin interpretation requires clinical context, as it can be falsely elevated in the presence of inflammation, chronic disease, malignancy, or liver disease 12, 13
  • If iron deficiency is confirmed, investigate the underlying cause, including gastrointestinal bleeding in adult men and postmenopausal women, and menstrual losses in premenopausal women 13

Alternative Diagnoses

  • If iron studies are normal, consider hemoglobinopathies, such as thalassemia trait, and obtain hemoglobin electrophoresis, particularly in patients with appropriate ethnic background 12
  • If iron studies are normal, consider chronic disease and assess for underlying inflammatory conditions 13, 14

Anemia Diagnosis and Treatment

Initial Laboratory Tests

  • The National Kidney Foundation recommends ordering absolute reticulocyte count to evaluate bone marrow response, transferrin saturation, and vitamin B12 and folate levels in patients with anemia 15
  • The Kidney International guideline suggests that transferrin saturation and vitamin B12 and folate levels should be measured in all patients with anemia to evaluate for iron deficiency and other causes of anemia 15

Treatment Approach Based on Etiology

  • The Kidney International guideline recommends that for chronic kidney disease patients not on dialysis with TSAT ≤ 30% and ferritin ≤ 500 ng/ml, a 1-3 month trial of oral iron OR intravenous iron should be considered 15
  • The Kidney International guideline suggests that parenteral iron should be reserved for patients who cannot tolerate or absorb oral preparations, or when rapid repletion is needed 15

Evaluation of Iron Deficiency Anemia

Diagnostic Criteria

  • The American Society of Hematology suggests that low MCH with elevated RDW is highly suggestive of iron deficiency, even when other CBC parameters remain normal, and recommends obtaining iron studies to confirm the diagnosis and guide treatment 16
  • The presence of low MCH with elevated RDW specifically suggests iron-deficient erythropoiesis, even before frank anemia develops, with a sensitivity of 72% for detecting iron deficiency in patients with anemia 16

Clinical Presentation

  • The bone marrow produces red blood cells with progressively less hemoglobin content, resulting in low MCH, and both normal-sized older cells and smaller, hypochromic newer cells coexist in circulation, creating a high RDW 16
  • Hemoglobin and hematocrit may still appear "normal" because the anemia is just beginning to develop, but this pattern indicates evolving iron deficiency that will progress to overt anemia if untreated 16

Diagnostic Approach to Low Hemoglobin with Elevated RDW-CV

Monitoring and Treatment

  • The American Society of Hematology recommends monitoring iron status during treatment to assess response and detect potential iron overload 17, 18

Investigation for Underlying Cause

  • The American Gastroenterological Association suggests that all adult men and postmenopausal women with confirmed iron deficiency require endoscopic evaluation to exclude gastrointestinal malignancy, regardless of anemia severity, although the exact citation is not provided, a similar recommendation is found in 17, 18

Diagnostic Approach to Anemia

Initial Evaluation

  • The American Society of Clinical Oncology recommends evaluating for hemolysis by measuring haptoglobin, LDH, indirect bilirubin, and examining peripheral smear for schistocytes in patients with normocytic anemia 19
  • The American Journal of Hematology suggests that folate and B12 deficiency are rare in cancer patients, and testing should be reserved for patients with high clinical suspicion such as elevated MCV or neurologic symptoms 20

Special Populations

  • The American Journal of Hematology notes that the etiology of cancer-related anemia can be traced to production, destruction, or loss of red blood cells, and folate and B12 deficiency are rare in these patients 20

Evaluation of Macrocytic Anemia with Low RDW

Laboratory Interpretation

  • Low RDW (< 14 %) together with an elevated MCV indicates a uniform population of enlarged red cells, helping to differentiate macrocytic anemia from iron‑deficiency anemia, which typically shows a high RDW. 21
  • A low or normal reticulocyte count points to impaired erythropoiesis (e.g., vitamin B12/folate deficiency or bone‑marrow failure), whereas an elevated reticulocyte count suggests hemolysis or recent marrow regeneration. 21

Primary Etiologies

  • Megaloblastic anemia (vitamin B12 or folate deficiency) characteristically presents with macrocytosis and a low/normal reticulocyte count. 21
  • Thiopurine therapy (azathioprine, 6‑mercaptopurine) frequently produces homogeneous macrocytosis, especially in patients with inflammatory bowel disease. 21, 22, 23

Diagnostic Workup

First‑Line Laboratory Tests

  • Measure serum vitamin B12 and folate levels to confirm or exclude megaloblastic anemia. 21
  • Obtain a peripheral blood smear to look for hypersegmented neutrophils (megaloblastic), oval macrocytes, or pancytopenic patterns. 21
  • If the reticulocyte count is elevated, assess hemolysis with haptoglobin, lactate dehydrogenase, and indirect bilirubin. 21
  • Serum ferritin and transferrin saturation should be checked to rule out co‑existing iron deficiency, which can mask macrocytosis and normalize the MCV. 21

Targeted Additional Studies

  • When pancytopenia is identified, a bone‑marrow examination is warranted to evaluate for aplastic anemia or myelodysplastic syndrome. (cited in the source text without a specific reference; therefore omitted per instructions).
  • If iron studies reveal ferritin < 30 µg/L (or < 100 µg/L with inflammation), iron deficiency may be present and could be concealing a more severe macrocytic process. 22, 23

Clinical History Priorities

  • Review medication exposure, focusing on thiopurines, chemotherapy agents, anticonvulsants, and methotrexate, as these can induce macrocytosis. 21, 22
  • Assess gastrointestinal history (diarrhea, malabsorption, prior gastric surgery) that raises the risk of vitamin B12 deficiency. 21

Common Pitfalls

  • Mixed micro‑ and macro‑cytosis can neutralize the MCV, yielding a normal MCV but an elevated RDW; therefore, iron studies remain essential even when RDW is low. 21

Practical Algorithm

  • Measure vitamin B12 and folate levels.
  • Perform thyroid‑stimulating hormone and liver‑function tests.
  • Conduct a thorough medication review for agents known to cause macrocytosis.
  • Consider bone‑marrow referral if pancytopenia is present.
    (All steps supported by citations 21 and 22.)
  • Evaluate for hemolysis with haptoglobin, LDH, indirect bilirubin, and peripheral smear.
    (Supported by citation 21.)

Distinguishing Iron‑Deficiency Anemia from Thalassemia Trait Using Laboratory Parameters

Diagnostic Criteria

Laboratory Evaluation

Iron‑Status Tests

Bone‑Marrow Response

Assessment for Malabsorption

Management of Thalassemia Trait

Management of Iron Deficiency Anemia

Oral Iron Therapy

  • The Centers for Disease Control and Prevention (CDC) recommends that adults with confirmed iron deficiency start oral iron supplementation (e.g., ferrous sulfate 325 mg taken once to three times daily) and monitor for a rise in hemoglobin, which confirms the diagnosis of iron‑deficiency anemia. 26

Monitoring Treatment Response

  • According to the CDC, an increase in hemoglobin after therapeutic iron supplementation serves as a reliable indicator that the anemia is due to iron deficiency. 26

Racial Considerations in Diagnostic Criteria

  • The CDC notes that applying uniform hemoglobin cut‑offs leads to higher false‑positive rates for iron deficiency in Black patients; therefore, clinicians should incorporate additional iron status tests such as serum ferritin and transferrin saturation rather than relying solely on hemoglobin levels. 26

Iron Deficiency Diagnosis and Mixed‑Deficiency Pitfalls

Interpretation of Ferritin and Transferrin Saturation

Hemolysis Evaluation in Anemia Workup

Initial Laboratory Assessment

Additional Diagnostic Steps

Evidence‑Based Recommendations for Anemia Workup

Reticulocyte Assessment

  • An absolute reticulocyte count helps differentiate impaired erythropoiesis (low/normal count) from hemolysis or acute blood loss (elevated count)【29】.
  • A low or normal reticulocyte count in the setting of anemia signals an inadequate bone‑marrow response and warrants evaluation for nutritional deficiencies, chronic disease, or marrow disorders【29】.

Iron‑Related Testing

  • A comprehensive iron studies panel should include serum ferritin, transferrin saturation (TSAT), and total iron‑binding capacity (TIBC) to assess both iron stores and iron availability for hemoglobin synthesis【29】.
  • TSAT values below 15‑20 % support a diagnosis of iron deficiency and are less influenced by inflammation than ferritin levels【29】.

Micronutrient and Endocrine Evaluation

  • Serum vitamin B12 and folate measurements are recommended to confirm or exclude megaloblastic anemia【29】.
  • Thyroid‑stimulating hormone (TSH) testing should be performed to rule out hypothyroidism, a common reversible cause of anemia that can mimic erythropoietin deficiency【29】.

Targeted Gastrointestinal Screening

  • When iron deficiency is confirmed, a stool guaiac test for occult blood is advised to investigate possible gastrointestinal bleeding【29】.

Anemia Evaluation in Chronic Kidney Disease and Iron Deficiency

Screening for Gastrointestinal Blood Loss

  • Stool guaiac testing should be performed when iron‑deficiency anemia is confirmed to detect occult gastrointestinal bleeding. 30

Assessment of Bone Marrow Response in Normocytic Anemia

  • A reticulocyte index ≤ 2 in normocytic anemia indicates an inadequate marrow response; order vitamin B12, folate, thyroid‑stimulating hormone testing, and evaluate renal function (serum creatinine and eGFR) to identify possible chronic kidney disease. 30

Renal Function Evaluation in Anemic Patients

  • Serum creatinine and estimated glomerular filtration rate should be measured in patients with anemia to assess for chronic kidney disease. 30

Etiology of Anemia in Advanced Kidney Disease

  • In patients with serum creatinine ≥ 2 mg/dL and normocytic, normochromic anemia without another identifiable cause, erythropoietin deficiency is the most likely primary etiology. 30

Erythropoietin Testing Recommendation

  • Routine measurement of serum erythropoietin levels is generally not indicated in patients with chronic kidney disease–related anemia. 30

Evidence‑Based Guidelines for the Diagnosis of Anemia

Morphologic Classification and RDW

  • An elevated red‑cell distribution width (RDW) together with microcytosis strongly suggests iron‑deficiency anemia, even when the mean corpuscular volume (MCV) is only borderline low. 31
  • Mixed nutrient deficiencies (e.g., iron + vitamin B12 or folate) can normalize MCV while raising RDW; therefore iron studies should be performed even when MCV appears normal. 31

Reticulocyte Count Guidance

  • A low or normal reticulocyte index (< 2.0) indicates inadequate marrow response and directs further testing based on MCV (e.g., iron studies for microcytic anemia, renal and vitamin assessments for normocytic anemia, B12/folate for macrocytic anemia). 31
  • An elevated reticulocyte index (> 2.0) points to an appropriate marrow response, prompting evaluation for hemolysis or acute blood loss with haptoglobin, lactate dehydrogenase, indirect bilirubin, and peripheral‑smear examination for schistocytes or spherocytes. 31

Iron Studies Interpretation

  • In the absence of inflammation (normal C‑reactive protein), a serum ferritin < 30 µg/L confirms iron deficiency. 31
  • When inflammation is present (elevated CRP), ferritin may be falsely high; a transferrin saturation < 15–20 % should be used as the primary indicator of iron deficiency. 31
  • In patients with inflammatory bowel disease or other chronic inflammatory conditions, ferritin values up to 100 µg/L can still be compatible with iron deficiency. 31

Hemolysis Evaluation

  • An elevated reticulocyte count warrants a hemolysis work‑up that includes low haptoglobin, increased LDH, raised indirect bilirubin, and a peripheral smear for fragmented red cells; a direct antiglobulin (Coombs) test should be added if autoimmune hemolysis is suspected. 31

Diagnostic Pitfalls

  • Interpreting ferritin without concurrent CRP measurement can miss iron deficiency because inflammation raises ferritin independently of iron stores. 31
  • Combined iron and vitamin B12/folate deficiencies may mask each other on MCV assessment while producing a high RDW; both iron and vitamin studies must be ordered. 31
  • Classification of anemia should always incorporate both MCV and RDW, and the reticulocyte index should be used to differentiate impaired erythropoiesis from hemolysis or bleeding. 31
  • Iron studies must be interpreted in the context of inflammatory markers (CRP) to avoid false‑negative diagnoses. 31

Alpha Thalassemia in Southeast Asian Elderly Patients

Epidemiology

  • Alpha thalassemia is the leading cause of microcytic anemia in Southeast Asian populations, responsible for 28 %–55 % of cases in this demographic. 32

Diagnostic Screening

  • Mean Cell Volume (MCV) screening: An MCV < 80 fL reliably identifies carriers of alpha‑thalassemia; the patient’s MCV of 73.4 fL falls well below this threshold, supporting a carrier state. 32

Management Recommendations

  • Genetic counseling should be offered to individuals of reproductive age who carry the alpha‑thalassemia trait, because offspring of two carriers are at risk for the lethal homozygous form (Bart’s hydrops fetalis). 32

Evaluation of Coexisting Iron Deficiency in the Elderly

  • In elderly patients with microcytic anemia, gastrointestinal blood loss is the most common cause of iron deficiency; therefore, an upper endoscopy with duodenal biopsies and a colonoscopy are recommended to exclude malignancy, angiodysplasia, or celiac disease. 33

Guideline‑Based Evaluation and Management of Anemia in Young Adults

Diagnostic Evaluation

  • Complete blood count with red‑cell indices (MCV, MCH, MCHC, RDW) is the first‑line test to classify anemia by size and to detect patterns such as microcytosis or an elevated RDW that point toward iron deficiency. 34, 35
  • Reticulocyte count (absolute or index) distinguishes impaired erythropoiesis (low/normal reticulocytes) from hemolysis or acute blood loss (elevated reticulocytes). 36
  • A panel of iron studies (serum ferritin, transferrin saturation, total iron‑binding capacity) is required to confirm or exclude iron deficiency. 36
  • Peripheral blood smear examination evaluates red‑cell morphology, identifies hypersegmented neutrophils (suggesting B12/folate deficiency) or schistocytes (suggesting hemolysis). 36

Evidence level: not specified in the cited sources.

Indicators of Microcytic Anemia

  • An elevated red‑cell distribution width (RDW > 14 %) together with a low MCV strongly suggests iron‑deficiency anemia, even when the MCV is only marginally reduced. 34, 35
  • Transferrin saturation < 15–20 % supports iron deficiency and is less influenced by inflammatory states than ferritin. 36
  • Thalassemia trait typically presents with marked microcytosis (MCV < 75 fL), low MCH, a normal or low‑normal RDW (< 14 %), and normal iron studies; hemoglobin electrophoresis is indicated in at‑risk ethnic groups. 34, 35

Evidence level: not specified.

Interpretation of Iron Studies in the Presence of Inflammation

  • When systemic inflammation is present (elevated C‑reactive protein), transferrin saturation < 15–20 % should be used as the primary indicator of iron deficiency because ferritin may be falsely elevated. 36

Evidence level: not specified.

Treatment Monitoring for Iron‑Deficiency Anemia

  • A rise in hemoglobin after 4–6 weeks of oral ferrous sulfate therapy confirms iron‑deficiency anemia as the underlying diagnosis. 34, 35
  • If hemoglobin does not improve, clinicians should reassess adherence, evaluate for ongoing occult bleeding or malabsorption, repeat iron studies, and consider alternative diagnoses such as thalassemia trait or anemia of chronic disease. 34, 35

Evidence level: not specified.

Anemia Diagnostic Workup: Evidence‑Based Laboratory Evaluation

Initial Laboratory Assessment

  • Determining the mean corpuscular volume (MCV) allows classification of anemia as microcytic (< 80 fL), normocytic (80–100 fL), or macrocytic (> 100 fL), which substantially narrows the differential diagnosis. 37
  • Obtaining an absolute reticulocyte count differentiates impaired erythropoiesis (low/normal count) from hemolysis or acute blood loss (elevated count). 38

Iron Status Evaluation

  • A serum ferritin level below 30 µg/L confirms iron deficiency when inflammation is absent. 37
  • A transferrin saturation below 15–20 % supports iron deficiency and is less influenced by inflammatory states than ferritin. 38

Reticulocyte Count Interpretation

  • A low or normal reticulocyte count (< 2 %) indicates an inadequate bone‑marrow response, prompting evaluation for nutritional deficiencies (iron, vitamin B12, folate), chronic kidney disease, or primary marrow disorders. 38

MCV‑Based Diagnostic Algorithms

Microcytic Anemia (MCV < 80 fL)

  • Iron deficiency remains the most common cause; confirmation should be obtained with ferritin and transferrin‑saturation measurements. 37

Normocytic Anemia (MCV 80–100 fL)

  • Assessment of serum creatinine and estimated glomerular filtration rate (eGFR) is recommended to identify chronic kidney disease as a source of erythropoietin deficiency. 38

Macrocytic Anemia (MCV > 100 fL)

  • Initial testing should include serum vitamin B12 and folate levels to detect megaloblastic anemia. 37

Iron‑Deficiency Anemia: Diagnosis and Management Guidelines

Diagnostic Criteria

  • The presence of low hemoglobin (~99 g/L), microcytosis (MCV ≈ 77 fL), low MCH (≈ 22 pg), and markedly elevated RDW (≈ 18 %) is pathognomonic for iron‑deficiency anemia. [39][40]
  • An elevated RDW (> 14 %) helps differentiate iron‑deficiency anemia from thalassemia trait, which typically shows a normal or only slightly raised RDW (≤ 14 %). [39][40]

Laboratory Evaluation

  • Serum ferritin < 30 µg/L confirms iron deficiency when inflammation is absent; if C‑reactive protein is elevated, ferritin values up to 100 µg/L may still indicate deficiency. [39][41]40
  • Transferrin saturation < 15–20 % supports iron deficiency and is less affected by inflammatory states. 41
  • An absolute reticulocyte count that is low or inappropriately normal demonstrates inadequate bone‑marrow response, consistent with iron‑deficiency anemia rather than hemolysis or acute blood loss. 39
  • C‑reactive protein should be measured concurrently with ferritin to rule out false‑elevated ferritin due to inflammation, infection, or malignancy. 39

Gastrointestinal Evaluation

  • All adult men and post‑menopausal women with confirmed iron‑deficiency anemia require bidirectional endoscopy (upper endoscopy with duodenal biopsies plus colonoscopy) to exclude gastrointestinal malignancy, even when fecal immunochemical testing is normal. [41][40]
  • Upper endoscopy should include small‑bowel biopsies because 2–3 % of patients with iron‑deficiency anemia have celiac disease as the underlying cause. 41
  • The most common gastrointestinal sources of occult blood loss are colon cancer, gastric cancer, angiodysplasia, NSAID‑induced gastropathy, and inflammatory bowel disease. [41][40]
  • In pre‑menopausal women, menstrual blood loss is the leading cause of iron deficiency, but gastrointestinal evaluation is still indicated if iron supplementation fails to correct anemia or if any gastrointestinal symptoms are present. 41

Treatment Monitoring

  • A rise in hemoglobin after 4–6 weeks of oral iron therapy (e.g., ferrous sulfate) confirms the diagnosis of iron‑deficiency anemia when other investigations are inconclusive. 41

Clinical Pitfalls (What to Avoid)

  • Do not assume dietary insufficiency alone as the cause of iron deficiency in adults; occult gastrointestinal blood loss must be ruled out. [41][40]
  • Do not interpret ferritin without simultaneous C‑reactive protein measurement, because inflammation can mask true iron deficiency by artificially elevating ferritin levels. 39
  • Do not confuse iron‑deficiency anemia with thalassemia trait; thalassemia typically presents with marked microcytosis (MCV < 75 fL), normal or low‑normal RDW (< 14 %), and normal iron studies, warranting hemoglobin electrophoresis when iron studies are normal. 40
  • Do not delay gastrointestinal evaluation while treating with iron supplementation, as early detection of gastrointestinal malignancy significantly improves morbidity and mortality outcomes. [41][40]

REFERENCES

5

cancer- and chemotherapy-induced anemia. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

8
11

aaos management of hip fractures in older adults evidence-based clinical practice guideline. [LINK]

The Journal of the American Academy of Orthopaedic Surgeons, 2022

13
14

cancer- and chemotherapy-induced anemia. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

20

diagnosis and treatment of cancer-related anemia. [LINK]

American Journal of Hematology, 2014

32
33

cancer- and chemotherapy-induced anemia. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012